Document Detail

Expanded clinical evaluation of lovastatin (EXCEL) study results. II. Assessment of the human lens after 48 weeks of treatment with lovastatin.
MedLine Citation:
PMID:  1998274     Owner:  NLM     Status:  MEDLINE    
The crystalline lenses of hypercholesterolemic patients were assessed before and after 48 weeks of treatment with lovastatin or placebo to determine the effect of lovastatin on the human lens. Patients were given a biomicroscopic (slit-lamp) examination of the lens, and a previously validated, standardized classification system was used to describe the findings. A total of 8,245 patients were randomly assigned in equal numbers to treatment with placebo or lovastatin 20 or 40 mg once or twice daily in this double-blind, parallel-group study. Statistical analyses of the distribution of cortical, nuclear and subcapsular opacities at 48 weeks, adjusted for age and presence of an opacity at baseline, showed no significant differences (p less than 0.01) between the placebo and lovastatin-treated groups. Visual acuity assessments at week 48 were also not found to have significantly different distributions among treatment groups. Moreover, no significant differences were found among the groups in the frequencies of greater than or equal to 2-line worsening in visual acuity with concurrent progression in lenticular opacity, cataract extraction, or any spontaneously reported adverse ophthalmologic experience. No evidence was found for an effect of lovastatin on the human lens after 48 weeks of treatment.
A M Laties; C L Shear; E A Lippa; A L Gould; H R Taylor; D P Hurley; W P Stephenson; E U Keates; M A Tupy-Visich; A N Chremos
Related Documents :
25446724 - The yoruba version of the beck hopelessness scale: psychometric characteristics and cor...
25415764 - Assessment of dissociation in bosnian treatment-seeking refugees in denmark.
17270674 - Subgroup analysis of the marina study of ranibizumab in neovascular age-related macular...
21624554 - Meta-analysis of randomized trials focusing on prevention of the postpericardiotomy syn...
1326404 - Sumatriptan injection is superior to placebo in the acute treatment of migraine--with r...
22986424 - "unequivocally abnormal" vs "usual" signs and symptoms for proficient diagnosis of diab...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The American journal of cardiology     Volume:  67     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  1991 Mar 
Date Detail:
Created Date:  1991-04-01     Completed Date:  1991-04-01     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  447-53     Citation Subset:  AIM; IM    
Scheie Eye Institute, Department of Ophthalmology, University of Pennsylvania School of Medicine, Philadelphia 19104.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cataract / chemically induced
Double-Blind Method
Hypercholesterolemia / drug therapy
Lens, Crystalline / drug effects*,  pathology
Lovastatin / adverse effects*,  therapeutic use
Middle Aged
Visual Acuity / drug effects
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Public health. Childhood lead exposure in Wisconsin in 1990.
Next Document:  Effect of left ventricular aneurysm on risk of sudden and nonsudden cardiac death.